当前位置:首页 - 行情中心 - 申联生物(688098) - 财务分析 - 现金流量表

申联生物

(688098)

  

流通市值:39.67亿  总市值:39.67亿
流通股本:4.11亿   总股本:4.11亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金146,597,121.0574,767,697.9734,850,686.15327,771,275.35
  收到其他与经营活动有关的现金13,216,306.4310,580,357.573,360,353.2318,593,903.97
  经营活动现金流入小计159,813,427.4885,348,055.5438,211,039.38346,365,179.32
  购买商品、接受劳务支付的现金39,621,687.2426,721,310.9816,493,455.8463,146,100.16
  支付给职工以及为职工支付的现金59,830,942.1143,725,024.4126,864,266.1986,752,716.75
  支付的各项税费9,544,113.966,461,858.112,270,549.4915,062,479.97
  支付其他与经营活动有关的现金68,922,778.2947,828,915.5221,143,723.4692,041,835.77
  经营活动现金流出小计177,919,521.6124,737,109.0266,771,994.98257,003,132.65
  经营活动产生的现金流量净额-18,106,094.12-39,389,053.48-28,560,955.689,362,046.67
二、投资活动产生的现金流量:
  收回投资收到的现金476,000,000352,000,000239,000,0001,025,223,528.42
  取得投资收益收到的现金914,545.51679,898.91438,431.612,289,232.37
  处置固定资产、无形资产和其他长期资产收回的现金净额517,0007,000--
  投资活动现金流入小计477,431,545.51352,686,898.91239,438,431.611,027,512,760.79
  购建固定资产、无形资产和其他长期资产支付的现金34,279,805.2121,658,558.859,790,027.9684,910,379.64
  投资支付的现金459,500,000347,500,000214,000,000946,280,000
  投资活动现金流出小计493,779,805.21369,158,558.85223,790,027.961,031,190,379.64
  投资活动产生的现金流量净额-16,348,259.7-16,471,659.9415,648,403.65-3,677,618.85
三、筹资活动产生的现金流量:
  取得借款收到的现金---14,000,000
  收到其他与筹资活动有关的现金16,317.3816,317.3810,671.9295,346.51
  筹资活动现金流入小计16,317.3816,317.3810,671.9214,095,346.51
  偿还债务支付的现金560,000560,000--
  分配股利、利润或偿付利息支付的现金202,202135,22668,25014,347,206.67
  支付其他与筹资活动有关的现金2,008,660.952,016,651.581,856,900.6919,104,225.37
  筹资活动现金流出小计2,770,862.952,711,877.581,925,150.6933,451,432.04
  筹资活动产生的现金流量净额-2,754,545.57-2,695,560.2-1,914,478.77-19,356,085.53
四、汇率变动对现金及现金等价物的影响-17.51-6.29-2.1541.13
五、现金及现金等价物净增加额-37,208,916.9-58,556,279.91-14,827,032.8766,328,383.42
  加:期初现金及现金等价物余额111,169,093.8111,169,093.8111,169,093.844,840,710.38
  期末现金及现金等价物余额73,960,176.952,612,813.8996,342,060.93111,169,093.8
补充资料:
  净利润--15,042,391.78--48,748,564.39
  资产减值准备--12,977.32-28,177,425.29
  固定资产和投资性房地产折旧-31,639,949.28-59,189,281.14
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-31,639,949.28-59,189,281.14
  无形资产摊销-4,860,951.56-8,912,564.49
  处置固定资产、无形资产和其他长期资产的损失-46,839.3--35,769.23
  固定资产报废损失---281,640.19
  公允价值变动损失--2,157,584.14--883,276.87
  财务费用-162,689.33-54,481.88
  投资损失--42,443.37--1,785,944.86
  递延所得税--1,243,546.3--7,933,567.13
  其中:递延所得税资产减少--1,563,058.77--8,122,940.58
    递延所得税负债增加-319,512.47-189,373.45
  存货的减少--1,345,091.91-16,682,046.7
  经营性应收项目的减少--27,898,980.31-5,026,234.92
  经营性应付项目的增加--33,110,378.82-21,418,535.12
  现金的期末余额-52,612,813.89-111,169,093.8
  减:现金的期初余额-111,169,093.8-44,840,710.38
  现金及现金等价物的净增加额--58,556,279.91-66,328,383.42
公告日期2025-10-272025-08-302025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑